Massmedica S.A. (WSE:MSM)

Massmedica Statistics

Total Valuation

Massmedica has a market cap or net worth of PLN 15.55 million. The enterprise value is 23.68 million.

Market Cap	15.55M
Enterprise Value	23.68M

Important Dates

The next estimated earnings date is Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Massmedica has 2.41 million shares outstanding.

Current Share Class	2.41M
Shares Outstanding	2.41M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	78.83%
Owned by Institutions (%)	n/a
Float	278,159

Valuation Ratios

The trailing PE ratio is 23.00.

PE Ratio	23.00
Forward PE	n/a
PS Ratio	0.54
PB Ratio	2.74
P/TBV Ratio	2.77
P/FCF Ratio	40.34
P/OCF Ratio	10.32
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.36, with an EV/FCF ratio of 61.43.

EV / Earnings	35.02
EV / Sales	0.82
EV / EBITDA	13.36
EV / EBIT	15.57
EV / FCF	61.43

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 1.48.

Current Ratio	1.28
Quick Ratio	0.35
Debt / Equity	1.48
Debt / EBITDA	4.74
Debt / FCF	21.80
Interest Coverage	9.89

Financial Efficiency

Return on equity (ROE) is 12.37% and return on invested capital (ROIC) is 8.48%.

Return on Equity (ROE)	12.37%
Return on Assets (ROA)	4.21%
Return on Invested Capital (ROIC)	8.48%
Return on Capital Employed (ROCE)	20.14%
Weighted Average Cost of Capital (WACC)	3.86%
Revenue Per Employee	1.93M
Profits Per Employee	45,076
Employee Count	15
Asset Turnover	1.28
Inventory Turnover	1.22

Taxes

In the past 12 months, Massmedica has paid 219,093 in taxes.

Income Tax	219,093
Effective Tax Rate	24.47%

Stock Price Statistics

The stock price has increased by +8.93% in the last 52 weeks. The beta is 0.17, so Massmedica's price volatility has been lower than the market average.

Beta (5Y)	0.17
52-Week Price Change	+8.93%
50-Day Moving Average	4.43
200-Day Moving Average	4.11
Relative Strength Index (RSI)	70.34
Average Volume (20 Days)	5,595

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Massmedica had revenue of PLN 28.97 million and earned 676,133 in profits. Earnings per share was 0.28.

Revenue	28.97M
Gross Profit	12.45M
Operating Income	1.52M
Pretax Income	895,226
Net Income	676,133
EBITDA	1.77M
EBIT	1.52M
Earnings Per Share (EPS)	0.28

Balance Sheet

The company has 272,846 in cash and 8.40 million in debt, with a net cash position of -8.13 million or -3.37 per share.

Cash & Cash Equivalents	272,846
Total Debt	8.40M
Net Cash	-8.13M
Net Cash Per Share	-3.37
Equity (Book Value)	5.67M
Book Value Per Share	2.35
Working Capital	4.89M

Cash Flow

In the last 12 months, operating cash flow was 1.51 million and capital expenditures -1.12 million, giving a free cash flow of 385,476.

Operating Cash Flow	1.51M
Capital Expenditures	-1.12M
Free Cash Flow	385,476
FCF Per Share	0.16

Margins

Gross margin is 42.97%, with operating and profit margins of 5.25% and 2.33%.

Gross Margin	42.97%
Operating Margin	5.25%
Pretax Margin	3.09%
Profit Margin	2.33%
EBITDA Margin	6.12%
EBIT Margin	5.25%
FCF Margin	1.33%

Dividends & Yields

Massmedica does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	4.35%
FCF Yield	2.48%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Massmedica has an Altman Z-Score of 1.97 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.97
Piotroski F-Score	5